Many studies have shown that serum RBP4 levels correlate with several components of metabolic syndromes in humans, including hypertension [67, 69], dyslipidemia [69, 70], cardiovascular disease [71], and intra-abdominal fat mass [71–73]. This evidence concerns the gene RBP4 and metabolic syndrome.